1. Srivastava, S., et al., Developments in the diagnostic techniques of infectious diseases: rural and urban prospective. Advances in infectious diseases, 2018. 8(3): p. 121.
2. Chaudhary, N., A. Khare, and S. Jain, Comparison of Hematological Parameters in Various Acute Febrile Illnesses. National Journal of Laboratory Medicine. 2016 Jul, 2016. 5(3).
3. Pang, T. and R.W. Peeling, Diagnostic tests for infectious diseases in the developing world: two sides of the coin. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007. 101(9): p. 856-857.
4. Jia, H., et al., The attributable direct medical cost of healthcare associated infection caused by multidrug resistance organisms in 68 hospitals of China. BioMed research international, 2019. 2019.
5. Mehtar, S., How to cost and fund an infection control programme. Journal of Hospital Infection, 1993. 25(1): p. 57-69.
6. Lee, S.-M., et al., The clinical significance of changes in red blood cell distribution width in patients with community-acquired pneumonia. Clinical and experimental emergency medicine, 2016. 3(3): p. 139.
7. Tartar, A.S. and S.O. Balin, Geriatric urinary tract infections: The value of laboratory parameters in estimating the need for bacteremia and Intensive Care Unit. Pakistan journal of medical sciences, 2019. 35(1): p. 215.
8. Mardia, A., D. Gatot, and D. Lindarto. Comparison platelet indices in diabetic patients with and without diabetic foot ulcer. in IOP Conference Series: Earth and Environmental Science. 2018. IOP Publishing.
9. Giuliano, C., C.R. Patel, and P.B. Kale-Pradhan, A guide to bacterial culture identification and results interpretation. Pharmacy and Therapeutics, 2019. 44(4): p. 192.
10. Mandell, L.A., et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical infectious diseases, 2007. 44(Supplement_2): p. S27-S72.
11. El-Radhi, A., Fever in common infectious diseases. In clinical manual of fever in children (pp. 85-140). 2018, Springer, Cham.
12. Leekha, S., C.L. Terrell, and R.S. Edson. General principles of antimicrobial therapy. in Mayo Clinic Proceedings. 2011. Elsevier.
13. Akya, A., et al., Platelet indices as useful indicators of urinary tract infection. Iranian Journal of Pediatric Hematology and Oncology, 2019. 9(3): p. 159-165.
14. Demiray, O., E. Cevik, and F. Cuce, Association Between Complete Blood Count Parameters and Urinary Stone Disease. Iranian Red Crescent Medical Journal, 2016. 18(7).
15. Mohan, N., et al., Diagnostic Role of RDW & PDW as Early Markers of Sepsis in Chemotherapy Induced Febrile Neutropenia.
16. Kizilgul, M., et al., Components of the Complete Blood Count in Type 2 Diabetes Mellitus with Inadequate Glycemic Control. Dicle Tıp Dergisi, 2018. 45(2): p. 113-120.
17. Furer, V., et al., Absence of leukocytosis in bacteraemic pneumococcal pneumonia. Primary Care Respiratory Journal, 2011. 20(3): p. 276-281.
18. Rosales, C., Neutrophil: a cell with many roles in inflammation or several cell types? Frontiers in physiology, 2018. 9: p. 113.
19. Liu, H., et al., Procalcitonin: present and future. Irish Journal of Medical Science (1971-), 2015. 184(3): p. 597-605.
20. Catal, F., et al., Platelet parameters in children with upper urinary tract infection: is there a specific response? Renal failure, 2008. 30(4): p. 377-381.
21. Esme, M., et al., Infections in the elderly critically-Ill patients. Frontiers in medicine, 2019. 6: p. 118.
22. Wagenlehner, F., et al., Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert review of pharmacoeconomics & outcomes research, 2018. 18(1): p. 107-117.
23. Hajj, J., et al. The “centrality of sepsis”: a review on incidence, mortality, and cost of care. in Healthcare. 2018. Multidisciplinary Digital Publishing Institute.
24. Epstein, L., et al., Varying estimates of sepsis mortality using death certificates and administrative codes—United States, 1999–2014. Morbidity and Mortality Weekly Report, 2016. 65(13): p. 342-345.
25. Weycker, D., et al., Long-term mortality and medical care charges in patients with severe sepsis. Critical care medicine, 2003. 31(9): p. 2316-2323.
26. Lindenauer, P.K., et al., Volume, quality of care, and outcome in pneumonia. Annals of internal medicine, 2006. 144(4): p. 262-269.
27. Lee, I.R., et al., Mean platelet volume in young children with urinary tract infection. Scientific reports, 2015. 5(1): p. 1-6.
28. Greenhow, T.L., et al., The changing epidemiology of serious bacterial infections in young infants. The Pediatric infectious disease journal, 2014. 33(6): p. 595-599.
29. Nada, A.M., Red cell distribution width in type 2 diabetic patients. Diabetes, metabolic syndrome and obesity: targets and therapy, 2015. 8: p. 525.
30. Arhan, M., et al., The role of red cell distribution width as a marker in inflammatory bowel disease. Turkish Journal of Medical Sciences, 2011. 41(2): p. 227-234.
31. Bashir, A., et al., Role of platelet indices in patients with dengue infection in Red Sea State, Sudan. Int J Sci Res, 2015. 4(1): p. 1573-1576.
32. Aktar, F., et al., Diagnostic role of inflammatory markers in pediatric Brucella arthritis. Italian journal of pediatrics, 2016. 42(1): p. 1-6.
33. Kim, C.H., et al., An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Critical care, 2013. 17(6): p. 1-8.
34. Bello, S., et al., Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin. Respiratory medicine, 2015. 109(9): p. 1193-1206.